These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11788180)
1. Low dose sulprostone for termination of second and third trimester pregnancies. de Boer MA; van Gemund N; Scherjon SA; Kanhai HH Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):244-8. PubMed ID: 11788180 [TBL] [Abstract][Full Text] [Related]
2. Low-dose sulprostone for pregnancy termination in cases of fetal abnormality. Kanhai HH; Keirse MJ Prenat Diagn; 1993 Feb; 13(2):117-21. PubMed ID: 8464832 [TBL] [Abstract][Full Text] [Related]
3. Dinoprostone priming of the cervix prior to termination of midgestation pregnancy with sulprostone. Rietberg CC; Lotgering FK; Huikeshoven FJ Eur J Obstet Gynecol Reprod Biol; 1995 Jun; 60(2):157-60. PubMed ID: 7641968 [TBL] [Abstract][Full Text] [Related]
4. [Induced termination of second and third trimester pregnancy in women with scarred uterus]. Zou LY; Fan L Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):17-21. PubMed ID: 20367920 [TBL] [Abstract][Full Text] [Related]
5. Sulprostone for pregnancy termination in women with severe (pre-) eclampsia. van Gemund N; de Boer MA; van Selm M; Scherjon SA; Kanhai HH Hypertens Pregnancy; 2002; 21(2):115-22. PubMed ID: 12175439 [TBL] [Abstract][Full Text] [Related]
6. Medical management for termination of second and third trimester pregnancies: a comparison of strategies. De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361 [TBL] [Abstract][Full Text] [Related]
7. [Place of the sulprostone in therapeutic interruptions of the pregnancy]. Khemiri B; Ben Slama A; Hsini A; Bedis Chennoufi M; Sfar E; Chelli H; Bouchnak M; Maghrebi H Tunis Med; 2007 May; 85(5):405-8. PubMed ID: 17657928 [TBL] [Abstract][Full Text] [Related]
8. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study]. Verhulsdonk MT; Papatsonis DN; Heydanus R Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323 [TBL] [Abstract][Full Text] [Related]
9. Termination of normal and pathological pregnancy with Sulprostone. Fischer Z; Chwalisz K; Michałkiewicz W Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407 [TBL] [Abstract][Full Text] [Related]
10. [Premature termination of pregnancy in the 2nd and 3rd trimester. Serial administration of 1 mg gemeprost vaginal suppositories versus intravenous sulproston]. Müller T; Backe J; Rempen A Geburtshilfe Frauenheilkd; 1996 May; 56(5):234-8. PubMed ID: 8768060 [TBL] [Abstract][Full Text] [Related]
11. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study]. Willems FE Ned Tijdschr Geneeskd; 2004 Aug; 148(33):1656-7; author reply 1657. PubMed ID: 15455517 [No Abstract] [Full Text] [Related]
12. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study]. Stoutjesdijk JA; Alsma J; Wildschut HI Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1293-6. PubMed ID: 15279214 [TBL] [Abstract][Full Text] [Related]
13. Laminaria and sulprostone in second trimester pregnancy termination for fetal abnormalities. Chung YP; Hwa HL; Ko TM Int J Gynaecol Obstet; 1999 Apr; 65(1):47-52. PubMed ID: 10390099 [TBL] [Abstract][Full Text] [Related]
14. The effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities. Lo TK; Lau WL; Lai FK; Lam H; Tse HY; Leung WC; Chin RK Prenat Diagn; 2008 Jun; 28(6):508-11. PubMed ID: 18509869 [TBL] [Abstract][Full Text] [Related]
15. Use of sulprostone for induction of preoperative cervical dilation or uterine evacuation: a comparison among the effects of different treatment schedules. Fruzzetti F; Melis GB; Strigini F; Vettori C; Ricci C; Fioretti P Obstet Gynecol; 1988 Nov; 72(5):704-8. PubMed ID: 3173921 [TBL] [Abstract][Full Text] [Related]
16. Rupture of the cervix in a sulprostone induced abortion in the second trimester. Corrado F; D'Anna R; Cannata ML Arch Gynecol Obstet; 2000 Nov; 264(3):162-3. PubMed ID: 11129519 [TBL] [Abstract][Full Text] [Related]
17. Intravenous sulprostone infusion in the treatment of retained placenta. Stefanovic V; Paavonen J; Loukovaara M; Halmesmäki E; Ahonen J; Tikkanen M Acta Obstet Gynecol Scand; 2013 Apr; 92(4):426-32. PubMed ID: 22862433 [TBL] [Abstract][Full Text] [Related]
18. [The use of sulprostone (Nalador) in the evacuation of uterine contents. Apropos of 32 cases at the Department of Gynecology, University Hospital Center, Nîmes, over 2 years (a retrospective study)]. Marsollier C; Tailland ML; Courtieu C; Déchaud H; Marès P J Gynecol Obstet Biol Reprod (Paris); 1993; 22(4):399-404. PubMed ID: 8360440 [TBL] [Abstract][Full Text] [Related]
19. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins]. Krofta L; Calda P; Zizka Z; Parízek A; Hrusková H; Kapras J Ceska Gynekol; 1998 Oct; 63(5):414-7. PubMed ID: 9818502 [TBL] [Abstract][Full Text] [Related]